A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.

Схожие документы

• Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase.
  по: Pelemans, H, и др.
  Опубликовано: (1998)
• Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
  по: Anna Figueiredo, и др.
  Опубликовано: (2006-11-01)
• A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
  по: Harrigan, P, и др.
  Опубликовано: (2002)
• Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.
  по: Pelemans, H, и др.
  Опубликовано: (1997)
• A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.
  по: Pelemans, H, и др.
  Опубликовано: (1998)